Concepedia

Publication | Open Access

Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen

DOIFull Paper Access

88

Citations

24

References

2010

Year

Timothy L. Lash, Deirdre Cronin‐Fenton, Thomas P. Ahern, Carol L. Rosenberg, Kathryn L. Lunetta, Rebecca A. Silliman, Stephen Hamilton‐Dutoit, Jens Peter Garne, Marianne Ewertz, Henrik Toft Sørensen,
Acta Oncologica

Abstract

Breast cancer patients with indications for an SSRI may be prescribed citalopram - and possibly other SSRI - without adversely affecting the outcome of adjuvant therapy with tamoxifen.

References

YearCitations

Page 1